[文献资料]主要参考文献

Lemtuzumab plus CHOP as front‐line chemotherapy for patients with peripheral T‐cel lymphomas：a phase Ⅱ study .Phase Ⅱ study of alemtuzumabincombination with pentostatinin patients with T‐cel neoplasms .Phase Ⅲ trial of consolidation therapy with yttrium‐9 ......